QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 igc-pharma-expands-ongoing-phase-2-calma-clinical-trial-evaluating-investigational-drug-candidate-igc-ad1-for-agitation-in-alzheimers-disease

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE:IGC), a clinical-stage biotechnology com...

 igc-pharma-unit-enters-sale-of-assets-agreement-for-27m

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001326205/000118518525001326/igc8k100125.htm

 igc-pharma-adds-new-clinical-trial-site-to-ongoing-phase-2-study-evaluating-igc-ad1-investigational-drug-candidate-for-treating-agitation-in-alzheimers-disease

IGC Pharma, Inc. (NYSE: IGC) today announced the addition of a new clinical trial site to its ongoing Phase 2 study evaluating ...

 igc-pharma-releases-preclinical-data-on-tgr-63-showing-it-impacts-beta-amyloid-pathology-and-inhibits-tau-protein-aggregation-addressing-two-hallmarks-of-alzheimers-disease

IGC Pharma, Inc. (NYSE:IGC) today announced preclinical findings on TGR-63, the Company's investigational small-molecule ca...

 igc-pharma-reports-tgr-63-blocks-both-amyloid-and-tau-aggregation-in-alzheimers-advances-dual-action-therapy-approach

IGC Pharma, Inc. (NYSE:IGC) today announced preclinical findings on TGR-63, the Company's investigational small-molecule ca...

Core News & Articles

https://www.gov.ca.gov/2025/09/22/governor-newsom-signs-legislation-cutting-taxes-on-cannabis-promoting-the-long-term-success-o...

Core News & Articles

https://www.marijuanamoment.net/marijuana-industry-group-pushes-congress-for-tax-relief-and-to-apply-the-fix-retroactively-for-...

Core News & Articles

https://www.marijuanamoment.net/trumps-drug-czar-pick-says-marijuana-is-a-bipartisan-issue-but-admin-still-exploring-all-option...

Core News & Articles

https://x.com/AMartinelliWA/status/1966198351692763194

 ascendiant-capital-maintains-buy-on-igc-pharma-raises-price-target-to-45

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.25 to $...

 igc-pharma-announces-expansion-of-its-ongoing-phase-2-clinical-trial-evaluating-igc-ad1-for-treating-agitation-in-patients-with-alzheimers-disease

IGC Pharma, Inc. (NYSE:IGC) today announced the expansion of its ongoing Phase 2 clinical trial evaluating IGC-AD1, an investig...

Core News & Articles

https://www.marijuanamoment.net/new-republican-national-committee-chairman-supports-marijuana-legalization/

Core News & Articles

https://themarijuanaherald.com/2025/08/staffers-cannabis/

 igc-pharma-q1-eps-002-beats-003-estimate-sales-328000k-beat-326000k-estimate

IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 20...

Core News & Articles

https://www.marijuanamoment.net/key-voices-in-trumps-maga-movement-are-divided-on-marijuana-as-president-considers-rescheduling...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION